English
|
中文
HOME
NEWS
EVENTS
Conference
Exhibition
Laws & Regulations
About Us
CAIVD & CPCEM
CAIVD
CPCEM
VIEW
About VIEW
Editorial Board
Contact
Search
News
Home
>
News
In Vitro Diagnostic Industry in China - POCT III
2025-06-10
2. Dry Chemical Technology The biggest difference between “dry chemistry” and traditional “wet chemistry” (i.e., solution chemistry) is the media involved in the chemical reactions. In this method, the liqui..
IVD China last week: Thermo Fisher and Biomobio, Wondfo, Randox and Realbio, BD Medical
2025-06-09
Thermo Fisher and Biomobio Sign Strategic Agreement in Spatial Imaging Thermo Fisher Scientific and Biomobio have successfully concluded a strategic cooperation agreement for the EVOS S1000..
IVD China last week: Fapon and KIVDA, Agilent and MEGAROBO, WeGoBP
2025-05-27
Fapon and KIVDA Sign Strategic Agreement to Deepen China-Korea IVD Collaboration On 23 May, Fapon Biotech signed a strategic cooperation agreement with the Korea In Vitro Diagnostics Associ..
Xi arrives in Hanoi for state visit to Vietnam
2025-04-15
Chinese President Xi Jinping arrived in Hanoi on Monday to pay a state visit to Vietnam.
AdvaMed continues pressure on White House to exempt devices from tariffs
2025-04-09
AdvaMed and nine other healthcare organizations have continued to pressure the White House to exempt medical devices and critical supplies from the Trump administration’s ongoing tariff saga.
Switzerland Global Enterprise Visits CAIVD during CIIE to Foster Sino-Swiss Collaboration in In Vitro Diagnostics
2024-11-15
At the 7th China International Import Expo (CIIE), themed "New Era, Shared Future", representatives from 152 countries, regions, and organizations gathered for national and corporate exhibitions. On 8 November, Switze..
China NMPA Announces New Measures to Boost High-End Medical Device Innovation and Regulatory Support
2025-07-11
The National Medical Products Administration (NMPA) of China has introduced a series of strategic measures to accelerate the development of new-quality productivity in the high-end medical device sector.
VieCure Expands Precision Oncology Ecosystem Through Strategic Partnership with Guardant Health
2025-07-11
Original from: Access Newswire VieCure Inc., pioneer of an intelligent cancer care ecosystem that democratizes precision oncology for community-based practices, today announced a strategic partnership wit..
UK Aligning Great Britain's High-Risk IVD Standards With EU Specifications
2025-07-11
The UK government said Thursday that it will align its regulations on high-risk in vitro diagnostic devices that are sold in Great Britain to align with EU specifications and repeal regulations specific to COVID-19 tests.
Labcorp and NOWDx Collaborate to Expand Access to Rapid Syphilis Testing
2025-07-10
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today a new initiative with NOWDiagnostics (NOWDx), a leader in developing over-the-counter (OTC) and point-of-care (POC) diagnostic tests, to expand access to rapid syphilis testing. The companies will distribute First to Know® Syphilis Test kits at no cost to select community-based public health organizations across the country.
Quest Diagnostics to Offer FDA-Cleared Fujirebio Blood Test for Alzheimer's Disease
2025-07-10
Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, including advanced diagnostics for brain health, today announced it plans to offer laboratory testing based on the Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio in-vitro diagnostic (IVD) test from Fujirebio, a global leader in the field of high-quality IVD testing.
Leinco Technologies Acquires BioClin, Inc.'s Essential IVD Raw Material Antibody Clones, Bolstering Leinco’s IVD Raw Material Catalog Business
2025-07-09
Leinco Technologies, a leading global provider of in vitro diagnostic (IVD) raw materials, today announced the acquisition of BioClin, Inc.’s proprietary antibody clones used as IVD raw materials. This strategic partnership significantly expands Leinco’s portfolio of critical reagents for endocrine hormone research and diagnostic assays.
Quanterix Completes Acquisition Of Akoya Biosciences, Creating The First Integrated Platform Capable Of Measuring Biomarkers Across The Blood And Tissue Continuum
2025-07-09
Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced that it has completed its previously announced acquisition of Akoya Biosciences, Inc., establishing a scaled leader in the early detection of disease for the neurology, oncology and immunology markets.
In Vitro Diagnostic Industry in China - POCT VII
2025-07-08
The POCT Market 1. International Market Conditions The POCT market is large and has enjoyed sound growth. From 2008 to 2018, the sales volume of the global POCT market doubled, with an average annu..
IVD China last week: Siemens Healthineers, Snibe, Fosun Diagnostics, Medconn Diagnostics
2025-07-08
Siemens Healthineers Officially Launches First APAC Production Line for Laboratory Diagnostics Equipment Siemens Healthineers' first domestically produced high-end laboratory diagnostics system—the Atel..
Total:
3329
Pages:
222
First
Prev
1
2
3
4
..
222
Next
End